Health Catalyst Q1 2024 Adj EPS $0.05 Beats $0.03 Estimate, Sales $74.723M Miss $74.802M Estimate
Health Catalyst Q1 2024 Adj EPS $0.05 Beats $0.03 Estimate, Sales $74.723M Miss $74.802M Estimate
Health Catalyst 2024年第一季度調整後的每股收益爲0.05美元，超過0.03美元的預期，銷售額爲7,472.3萬美元，低於7,4802萬美元的預期
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $74.723 million which missed the analyst consensus estimate of $74.802 million by 0.10 percent. This is a 1.16 percent increase over sales of $73.868 million the same period last year.
Health Catalyst（納斯達克股票代碼：HCAT）公佈的季度收益爲每股0.05美元，比分析師共識估計的0.03美元高出66.67％。這與去年同期相比沒有變化。該公司公佈的季度銷售額爲7,472.3萬美元，比分析師普遍預期的7,480.2萬美元低0.10％。這比去年同期的7386.8萬美元的銷售額增長了1.16％。